Finance & Acquisition: Chimerix

Parents

2011: Antiviral pharma Chimerix raises $45M in series F venture round (2011)
2016: Chimerix Inc. (NASDAQ:CMRX) - 27% discount to net cash
2021: Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
2025: Jazz Pharma to acquire Chimerix for ~$935M in cash
Including the most recent fundraising round, Chimerix has raised more than $85 million, in addition to a $36.1 million grant from the NIAID, NIH
Oncoceutics
The series F round was led by New Leaf Venture Partners, joined by new investors Pappas Ventures and Morningside Group. Existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures also pa